A critical role for p38 map kinase in NF-κB signaling during intermittent hypoxia/reoxygenation

Biochemical and Biophysical Research Communications

Volumn 355, Issue 3, 2007, Pages 728-733

  Ryan, Silke ^a   McNicholas, Walter T ^a   Taylor, Cormac T ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Intermittent hypoxia; NF B; p38

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HYPOXIA; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REOXYGENATION; SIGNAL TRANSDUCTION;

AEROBIOSIS; ANAEROBIOSIS; ANOXIA; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; I-KAPPA B KINASE; NF-KAPPA B; OXYGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

BOVINAE;

EID: 33847267684     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.015     Document Type: Article

References (41)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328 (1993) 1230-1235
2. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., Redline S., D′Agostino R.B., Newman A.B., Lebowitz M.D., and Pickering T.G. Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study. Sleep heart health study. JAMA 283 (2000) 1829-1836
3. McNicholas W.T., and Bonsignore M.R. Sleep apnoea as an idependent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J. 129 (2007) 156-178
4. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., O'Connor G.T., Boland L.L., Schwartz J.E., and Samet J.M. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am. J. Respir. Crit. Care Med. 163 (2001) 19-25
5. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnoea syndrome. Circulation 112 (2005) 2660-2667
6. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., and Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82 (1997) 1313-1316
7. Ohga E., Tomita T., Wada H., Yamamoto H., Nagase T., and Ouchi Y. Effects of obstructive sleep apnoea on circulating ICAM-1, IL-8, and MCP-1. J. Appl. Physiol. 94 (2003) 179-184
8. Minoguchi K., Tazaki T., Yokoe T., Minoguchi H., Watanabe Y., Yamamoto M., and Adachi M. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnoea syndrome. Chest 126 (2004) 1473-1479
9. Li C., and Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 282 (2002) C227-C241
10. May M.J., and Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Semin. Cancer Biol. 8 (1997) 63-73
11. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
12. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18 (2000) 621-663
13. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
14. Harant H., de Martin R., Andrew P.J., Foglar E., Dittrich C., and Lindley I.J. Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-alpha involves the transcription factor NF-kappaB. J. Biol. Chem. 271 (1996) 26954-26961
15. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc. Am. Thorac. Soc. 2 (2005) 386-390 discussion 394-5
16. Dong C., Davis R.J., and Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20 (2002) 55-72
17. Cowan K.J., and Storey K.B. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 206 (2003) 1107-1115
18. Kumar S., Boehm J., and Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2 (2003) 717-726
19. Baeza-Raja B., and Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell 15 (2004) 2013-2026
20. Zhang N., Ahsan M.H., Zhu L., Sambucetti L.C., Purchio A.F., and West D.B. Regulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways. J. Inflamm. (Lond.) 2 (2005) 10
21. Ho R.C., Hirshman M.F., Li Y., Cai D., Farmer J.R., Aschenbach W.G., Witczak C.A., Shoelson S.E., and Goodyear L.J. Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. Am. J. Physiol. Cell Physiol. 289 (2005) C794-C801
22. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor kappaB-dependent genes in obstructive sleep apnea syndrome. Am. J. Resp. Crit. Care Med. 174 (2006) 824-830
23. Taylor C.T., Fueki N., Agah A., Hershberg R.M., and Colgan S.P. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-alpha. J. Biol. Chem. 274 (1999) 19447-19454
24. Taylor C.T., Furuta G.T., Synnestvedt K., and Colgan S.P. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc. Natl. Acad. Sci. USA 97 (2000) 12091-12096
25. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
26. Doherty L.S., Kiely J.L., Swan V., and McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea syndrome. Chest 127 (2005) 2076-2084
27. Engleman H.M., Martin S.E., and Douglas N.J. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax 49 (1994) 263-266
28. Greenberg H., Ye X., Wilson D., Htoo A.K., Hendersen T., and Liu S.F. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem. Biophys. Res. Commun. 343 (2006) 591-596
29. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 (2005) 11-18
30. Behr T.M., Nerurkar S.S., Nelson A.H., Coatney R.W., Woods T.N., Sulpizio A., Chandra S., Brooks D.P., Kumar S., Lee J.C., Ohlstein E.H., Angermann C.E., Adams J.L., Sisko J., Sackner-Bernstein J.D., and Willette R.N. Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation 104 (2001) 1292-1298
31. Liao P., Wang S.Q., Wang S., Zheng M., Zhang S.J., Cheng H., Wang Y., and Xiao R.P. p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ. Res. 90 (2002) 190-196
32. Steenbergen C. The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning. Basic Res. Cardiol. 97 (2002) 276-285
33. Li M., Georgakopoulos D., Lu G., Hester L., Kass D.A., Hasday J., and Wang Y. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 111 (2005) 2494-2502
34. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
35. Jijon H., Allard B., and Jobin C. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway. Cell Signal 16 (2004) 1023-1032
36. Prabhakar N.R. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J. Appl. Physiol. 90 (2001) 1986-1994
37. Schulz R., Mahmoudi S., Hattar K., Sibelius U., Olschewski H., Mayer K., Seeger W., and Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnoea impact of continuous positive airway pressure therapy. Am. J. Respir. Crit. Care Med. 162 (2000) 566-570
38. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnoea patients. Am. J. Respir. Crit. Care. Med. 165 (2002) 934-939
39. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 22 (2003) 3356-3366
40. Campbell J., Ciesielski C.J., Hunt A.E., Horwood N.J., Beech J.T., Hayes L.A., Denys A., Feldmann M., Brennan F.M., and Foxwell B.M. A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J. Immunol. 173 (2004) 6928-6937
41. Yuan G., Nanduri J., Bhasker C.R., Semenza G.L., and Prabhakar N.R. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J. Biol. Chem. 280 6 (2005) 4321-4328